Many men aim to improve their athletic performance, increase their energy, and sharpen their cognitive skills. However, for many men over the age of 40, achieving these goals can be challenging due to low testosterone levels. Low testosterone impacts millions of men globally, with 2.9% of males over 40 and 3.75% of males over 60 being prescribed some form of testosterone replacement therapy (TRT) to improve their libido, energy, and mood. The market size for TRT is projected to reach $2.9 billion by 2032, growing at a CAGR of 4.2%.
Currently, available TRT treatments require several sessions of injections, applying messy gels and creams, or having pellets inserted under the skin, all of which can be uncomfortable and inconvenient. MangoRx aims to change this with its newly FDA-approved oral testosterone replacement therapy called Prime powered by Kyzatrex®.
Mangoceuticals, Inc. (NASDAQ: MGRX), a men’s health and wellness telemedicine company behind the popular erectile dysfunction pill Mango, is introducing Prime as a clinically proven treatment to restore testosterone to healthy levels. Just two oral doses a day with food are as effective and less messy or painful than traditional creams or injections. The company highlights that its lymphatic absorption pathway minimizes liver impact, and its formulation is not affected by dietary or alcohol intake, offering consistent absorption.
Prime is marketed to males who are on another form of TRT treatment including injectables or pellets and those experiencing common symptoms of low testosterone. The ordering process is straightforward through MangoRx’s telemedicine platform. After completing an online telehealth visit, one of its medical providers will review and determine the appropriate dosage and strength. Combined with a low price of $224/month, this uncomplicated process is appealing to the product’s growing customer base.
Additionally, Prime offers significant value to Mangoceuticals through strong customer retention and recurring revenues. Once men begin TRT, they tend to remain on it long-term, providing consistent and predictable revenue streams for the company. Sales in MangoRx’s first quarter rose by 108%.
KYZATREX, the active ingredient in Prime, is a clinically tested oral testosterone, demonstrated to be up to 96% effective in restoring testosterone levels. In a six-month clinical trial of 139 men with low testosterone, 88% had healthy testosterone levels at day 90. The formula’s design provides a more balanced hormonal profile without the fluctuations typical of injectable therapies. Prime does not contribute to increased blood viscosity, thereby reducing the risk of erythrocytosis and eliminating the need for blood donation as part of treatment management.
The immediate oral testosterone undecanoate in Prime offers additional benefits. Its convenient administration method eliminates the need for needles, messy creams, and frequent trips to the doctor. This non-invasive approach reduces the risk of infections and discomfort associated with injections. The oral formulation is absorbed via the lymphatic system, improving bioavailability and resulting in fewer liver issues compared to other oral testosterone forms.
Prime also provides stable hormone levels, potentially leading to consistent testosterone levels with less aromatization to estrogen. This flexible dosing allows for easier adjustments to meet individual needs. Enhanced well-being, muscle mass, strength, improved bone density, better libido, and sexual function are among the many advantages.
Beyond medical breakthroughs, Prime aims to improve the overall quality of life for men by increasing endurance, strength, energy levels, and physical capabilities. The TRT also improves mood, reduces mood swings, enhances mental clarity, and improves focus and cognitive performance. By positively impacting testosterone levels, Prime contributes to a holistic approach to health, vitality, and overall well-being.
Low testosterone is a common condition that can be treated, although the options available today can be uncomfortable. Prime offers the first oral treatment, presenting a new option for men seeking to improve their health without the complications of traditional TRT methods.
